Biomedical Innovations to eliminate priority infectious diseases

Session titleCollaborative biomedical innovation in Africa to eliminate infectious diseases
CoordinatorLinet Atieno Otieno, Senior Communications Manager, DNDi Africa
HostsDrugs for Neglected Diseases initiative (DNDi)
Session Format
(select one)
Panel DiscussionWorkshopPlenary
ChairsChair: Dr. John Amuasi, ARNTD and Lancet Commission
Speaker 1
Dr. Khadija Yahya MalimaCommission on Science and Technology, TanzaniaInvited
Speaker 2
Dr. Kelly ChibaleH3DInvited
Speaker 3 (Civil
Dr. Monique WasunnaDrugs for Neglected Diseases initiativeConfirmed
Speaker 4
(Private sector)
Dr. Isaac ChikwanhaGlobal Health Innovative Technology (GHIT) FundConfirmed
Speaker 5
Dr. Janet ByaruhangaAUDA-NEPADInvited
Session Objectives1. To present existing African-led innovation initiatives and chart a course for future work.
2. To rally the global health community around African led innovation initiatives
Session AbstractBiomedical research in Africa is rapidly growing in innovation such as producing affordable and accessible medicines that meet African priority health needs.
It also includes a focus on basic science, diagnostics, and vaccines. This panel brings together leading actors from the continent developing, delivering, and funding current and future biomedical research that is led by African researchers, working hand in hand with affected communities, in Africa, for Africa and beyond.

Their efforts target some of the most neglected diseases on the planet, for which treatments, when available, are ineffective, unsafe, or unaffordable and the people hit
hardest by these diseases are poor, vulnerable, and stigmatized. Diverse research partnerships have, in African tradition, pooled and harnessed scarce resources
to impressive ends, tackling malaria, worms, bacterial and fungal diseases that cause disfigurement and stigma.

The panelists will share lessons learnt from powerful partnerships in Africa as well as African-led innovation initiatives and how this approach contributes to building
research collaborations and Africa’s pandemic preparedness as witnessed during the COVID 19 pandemic. Additionally, they will propose how to ensure continued success and progress in reaching the target of eliminating NTDs as a public health problem in in Africa by 2030.

Speaker topics
Dr. Kelly Chibale
H3D: Leading integrated Drug Discovery in Africa

Dr. Khadija Yahya-Malima
Commission on Science and Technology, Tanzania: From
drug development to Implementation

Dr. Janet Byaruhanga AUDA-NEPAD:
Innovative regulatory approaches

Dr. Monique Wasunna
DNDi Africa: Innovative Platforms to tackle NTDs in Africa.

Dr. Isaac Chikwanha
GHIT Fund: Funding end-to-end approaches to
beat NTDs Funding medical innovations for neglected populations.

Event Timeslots (1)

WS 1